Search Results - suresh+ambudkar

1 Results

Sort By:

BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research

Abstract: The National Cancer Institute''s Laboratory of Cell Biology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize bodipy conjugated tyrosine kinase inhibitors that are currently used in the clinic for the treatment of CML or gastric cancers. We are also...

Published: 7/25/2024 | Inventor(s): Suneet Shukla, Amanda Skoumbourdis, Craig Thomas, Suresh Ambudkar

Keywords(s): BODIPY-FL, nilotinib, Tasigna, Tyrosine Kinase Inhibitor (TKI)

Category(s): Application > Research Materials, Collaboration Sought > Licensing, TherapeuticArea > Oncology